Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies.
about
Allosteric cross-talk in chromatin can mediate drug-drug synergy.Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action.Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes.New Ru(ii) photocages operative with near-IR light: new platform for drug delivery in the PDT windowCymantrene, Cyrhetrene and Ferrocene Nucleobase Conjugates: Synthesis, Structure, Computational Study, Electrochemistry and Antitrypanosomal Activity
P2860
Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fighting Cancer with Transitio ...... hromatin Targeting Strategies.
@en
Fighting Cancer with Transitio ...... hromatin Targeting Strategies.
@nl
type
label
Fighting Cancer with Transitio ...... hromatin Targeting Strategies.
@en
Fighting Cancer with Transitio ...... hromatin Targeting Strategies.
@nl
prefLabel
Fighting Cancer with Transitio ...... hromatin Targeting Strategies.
@en
Fighting Cancer with Transitio ...... hromatin Targeting Strategies.
@nl
P2093
P2860
P921
P356
P1433
P1476
Fighting Cancer with Transitio ...... hromatin Targeting Strategies.
@en
P2093
Alessandra Magistrato
Curt A Davey
Giulia Palermo
Thibaud von Erlach
Tina Riedel
Ursula Rothlisberger
P2860
P304
P356
10.1002/CMDC.201500478
P5008
P577
2015-12-04T00:00:00Z
2016-06-20T00:00:00Z